< Список пользователей

Брылев Лев Вадимович

кбн, нс

Лаборатория функциональной биохимии нервной системы

Список публикаций

  1. Brylev L.V., Ataulina A., Fominykh V.V., Parshikov V., Vorobyeva A., Istomina E., Shikhirimov R., Salikov A., Zakharova M., Guekht A., Beghi E. The epidemiology of amyotrophic lateral sclerosis in Moscow (Russia). Amyotrophic Lateral Sclerosis &amp; Frontotemporal Degeneration. 2020. V. 21. N. 5-6. P. 410-415. DOI: 10.1080/21678421.2020.1752252.
  2. Averchenkov D.M., Bejsheeva M.T., Ivakina E.D., Fominykh V.V., Grazhdantseva L.Y., Ivashchenko R.A., Arzumanian N.S., Brylev L.V., Guekht A.B. Clinical case of levamisole-induced multifocal inflammatory leukoencephalopathy. Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. 2019. V. 119. N. 12. P. 106-114. DOI: 10.17116/jnevro2019119121106.
  3. Fominykh V.V., Brylev L.V., Gaskin V., Luzin R., Yakovlev A.A., Komoltsev I., Belousova I., Rosliakova A., Guekht A., Gulyaeva N.V. Neuronal damage and neuroinflammation markers in patients with autoimmune encephalitis and multiple sclerosis. Metabolic Brain Disease. 2019. V. 34. N. 5. P. 1473-1485. DOI: 10.1007/s11011-019-00452-x.
  4. Skalnaya A., Fominykh V.V., Ivashchenko R., Averchenkov D., Grazhdantseva L., Frigo N., Negasheva E., Dolya O., Brylev L.V., Guekht A. Neurosyphilis in the modern era: Literature review and case series. Journal Of Clinical Neuroscience. 2019. V. 69. P. 67-73. DOI: 10.1016/j.jocn.2019.08.033.
  5. Fominykh V.V., Vorobyeva A., Onufriev M.V., Brylev L.V., Zakharova M.N., Gulyaeva N.V. Interleukin-6, S-Nitrosothiols, and Neurodegeneration in Different Central Nervous System Demyelinating Disorders: Is There a Relationship?. Journal Of Clinical Neurology (Seoul, Korea). 2018. V. 14. N. 3. P. 327-332. DOI: 10.3988/jcn.2018.14.3.327.
  6. Fominykh V.V., Shevtsova T., Arzumanian N., Brylev L.V. Coexistence of multiple sclerosis and ankylosing spondylitis: Report of four cases from Russia and review of the literature. Journal Of Clinical Neuroscience. 2017. V. 44. P. 230-233. DOI: 10.1016/j.jocn.2017.06.031.
  7. Kukushkin M.L., Brylev L.V., Laskov V.B., Makarov N.S., Pizova N.V., Sokov E.L., Chefranova Z.Y., Sholomov I.I., Guekht A.B. Results of a randomized double blind parallel study on the efficacy and safety of tolpersione in patients with acute nonspecific low back pain. Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova. 2017. V. 117. N. 11. P. 69-78. DOI: 10.17116/jnevro201711711169-78.
  8. Brylev L.V., Zakharova M.N., Zavalishin I.A., Gulyaeva N.V. Disruption of blood-brain barrier in amyotrophic lateral sclerosis: An update. Neurochemical Journal. 2012. V. 6. N. 1. P. 64-70. DOI: 10.1134/S1819712411040064.
  9. Brylev L.V. Proteinase inhibitors in the cerebrospinal fluid in neurological diseases. Neurochemical Journal. 2009. V. 3. N. 3. P. 214-220. DOI: 10.1134/S1819712409030106.
  10. Brylev L.V., Nelkina E.N., Yakovlev A.A., Onufriev M.V., Shabalina A.A., Kostyreva M.V., Zakharova M.N., Zavalishin I.A., Gulyaeva N.V. Modulators of cystein proteases and cell-death markers in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurochemical Journal. 2009. V. 3. N. 2. P. 133-138. DOI: 10.1134/S1819712409020093.
  11. Brylev L.V., Yakovlev A.A., Onufriev M.V., Zakharova M.N., Zavalishin I.A., Gulyaeva N.V. Calpain-like and lactate dehydrogenase activities in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Neurochemical Journal. 2007. V. 1. N. 4. P. 326-333. DOI: 10.1134/S1819712407040101.

 

© 2021, IHNA RAS